2020 annual financial data
Inhibikase Therapeutics 2020 Net margin
Direct answer
Net margin was -411.94%.
Operating income was -2,818,492 USD and net income was -2,877,296 USD.
Operating cash flow was -1,129,355 USD.
Get free Inhibikase Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 698,468 USD
- Operating income
- -2,818,492 USD
- Net income
- -2,877,296 USD
- Operating cash flow
- -1,129,355 USD
Explore related company data
View all 2020 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Inhibikase Therapeutics financial years